Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons

Significance Fragile X syndrome (FXS), the most frequent form of inherited intellectual disability, is caused by the absence of the protein Fragile X Mental Retardation Protein (FMRP) in neurons. In the absence of FMRP, the translation of a high number of mRNAs is increased in glutamatergic synapses, leading to abnormal synaptic function. It is unclear whether FMRP individually controls each of these mRNAs and whether some mRNAs are more important for the pathology. This study shows that FMRP mostly associates with and controls one main mRNA target in neurons, diacylglycerol kinase kappa (Dgkκ), a master regulator that controls two key signaling pathways activating protein synthesis. The deregulation of Dgkκ could account for many of the symptoms associated with FXS and could represent a novel therapeutic target. Fragile X syndrome (FXS) is caused by the absence of the Fragile X Mental Retardation Protein (FMRP) in neurons. In the mouse, the lack of FMRP is associated with an excessive translation of hundreds of neuronal proteins, notably including postsynaptic proteins. This local protein synthesis deregulation is proposed to underlie the observed defects of glutamatergic synapse maturation and function and to affect preferentially the hundreds of mRNA species that were reported to bind to FMRP. How FMRP impacts synaptic protein translation and which mRNAs are most important for the pathology remain unclear. Here we show by cross-linking immunoprecipitation in cortical neurons that FMRP is mostly associated with one unique mRNA: diacylglycerol kinase kappa (Dgkκ), a master regulator that controls the switch between diacylglycerol and phosphatidic acid signaling pathways. The absence of FMRP in neurons abolishes group 1 metabotropic glutamate receptor-dependent DGK activity combined with a loss of Dgkκ expression. The reduction of Dgkκ in neurons is sufficient to cause dendritic spine abnormalities, synaptic plasticity alterations, and behavior disorders similar to those observed in the FXS mouse model. Overexpression of Dgkκ in neurons is able to rescue the dendritic spine defects of the Fragile X Mental Retardation 1 gene KO neurons. Together, these data suggest that Dgkκ deregulation contributes to FXS pathology and support a model where FMRP, by controlling the translation of Dgkκ, indirectly controls synaptic proteins translation and membrane properties by impacting lipid signaling in dendritic spine.

[1]  Pankaj Chopra,et al.  Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences. , 2014, Human molecular genetics.

[2]  Yannick Schwab,et al.  Autistic-Like Syndrome in Mu Opioid Receptor Null Mice is Relieved by Facilitated mGluR4 Activity , 2014, Neuropsychopharmacology.

[3]  Patrick E. Rothwell,et al.  Autism-Associated Neuroligin-3 Mutations Commonly Impair Striatal Circuits to Boost Repetitive Behaviors , 2014, Cell.

[4]  Raag D. Airan,et al.  Natural Neural Projection Dynamics Underlying Social Behavior , 2014, Cell.

[5]  S. Joseph,et al.  Fragile X mental retardation protein regulates translation by binding directly to the ribosome. , 2014, Molecular cell.

[6]  D. Muller,et al.  Reversal of activity‐mediated spine dynamics and learning impairment in a mouse model of Fragile X syndrome , 2014, The European journal of neuroscience.

[7]  H. Hara,et al.  The roles of diacylglycerol kinases in the central nervous system: review of genetic studies in mice. , 2014, Journal of pharmacological sciences.

[8]  C. Portera-Cailliau,et al.  The trouble with spines in fragile X syndrome: density, maturity and plasticity , 2013, Neuroscience.

[9]  J. Darnell,et al.  The translation of translational control by FMRP: therapeutic targets for FXS , 2013, Nature Neuroscience.

[10]  M. Bear,et al.  Fragile X mental retardation protein and synaptic plasticity , 2013, Molecular Brain.

[11]  David L. Nelson,et al.  The Unstable Repeats—Three Evolving Faces of Neurological Disease , 2013, Neuron.

[12]  B. Kieffer,et al.  Impaired Hippocampus-Dependent and Facilitated Striatum-Dependent Behaviors in Mice Lacking the Delta Opioid Receptor , 2013, Neuropsychopharmacology.

[13]  Uwe Ohler,et al.  FMR1 targets distinct mRNA sequence elements to regulate protein expression , 2012, Nature.

[14]  Hiromichi Sakai,et al.  Recent progress on type II diacylglycerol kinases: the physiological functions of diacylglycerol kinase δ, η and κ and their involvement in disease. , 2012, Journal of biochemistry.

[15]  Eunjoon Kim,et al.  Regulation of hippocampal long‐term potentiation and long‐term depression by diacylglycerol kinaseζ , 2012, Hippocampus.

[16]  M. Bear,et al.  Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice , 2012, Neuron.

[17]  Stephen T Warren,et al.  Molecular mechanisms of fragile X syndrome: a twenty-year perspective. , 2012, Annual review of pathology.

[18]  I. Mérida,et al.  Shaping up the membrane: diacylglycerol coordinates spatial orientation of signaling. , 2011, Trends in biochemical sciences.

[19]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[20]  J. Mandel,et al.  G–quadruplex RNA structure as a signal for neurite mRNA targeting , 2011, EMBO reports.

[21]  Wim E. Crusio,et al.  Genetic-Background Modulation of Core and Variable Autistic-Like Symptoms in Fmr1 Knock-Out Mice , 2011, PloS one.

[22]  Richard Paylor,et al.  Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic‐like responses , 2011, Autism research : official journal of the International Society for Autism Research.

[23]  Y. Bae,et al.  DGKι regulates presynaptic release during mGluR‐dependent LTD , 2011, The EMBO journal.

[24]  M. Bear,et al.  Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome , 2010, The Journal of Neuroscience.

[25]  M. Wenk,et al.  Characterization of Substrate Preference for Slc1p and Cst26p in Saccharomyces cerevisiae Using Lipidomic Approaches and an LPAAT Activity Assay , 2010, PloS one.

[26]  K. Fukunaga,et al.  Essential Role of Neuron-Enriched Diacylglycerol Kinase (DGK), DGKβ in Neurite Spine Formation, Contributing to Cognitive Function , 2010, PloS one.

[27]  C. Lord,et al.  Behavioural phenotyping assays for mouse models of autism , 2010, Nature Reviews Neuroscience.

[28]  M. Didriksen,et al.  Nest building performance following MPTP toxicity in mice , 2010, Behavioural Brain Research.

[29]  A. El-Husseini,et al.  Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome , 2010, Behavioural Brain Research.

[30]  Eunjoon Kim,et al.  Diacylglycerol kinases in the regulation of dendritic spines , 2010, Journal of neurochemistry.

[31]  E. Klann,et al.  Dysregulation of mTOR Signaling in Fragile X Syndrome , 2010, The Journal of Neuroscience.

[32]  Y. Bae,et al.  Synaptic removal of diacylglycerol by DGKζ and PSD‐95 regulates dendritic spine maintenance , 2009, The EMBO journal.

[33]  Yolanda de Diego-Otero,et al.  α-Tocopherol Protects Against Oxidative Stress in the Fragile X Knockout Mouse: an Experimental Therapeutic Approach for the Fmr1 Deficiency , 2009, Neuropsychopharmacology.

[34]  R. Anwyl Metabotropic glutamate receptor-dependent long-term potentiation , 2009, Neuropharmacology.

[35]  J. Zhu,et al.  Ras Signaling Mechanisms Underlying Impaired GluR1-Dependent Plasticity Associated with Fragile X Syndrome , 2008, The Journal of Neuroscience.

[36]  G. Lynch,et al.  Brain-Derived Neurotrophic Factor Rescues Synaptic Plasticity in a Mouse Model of Fragile X Syndrome , 2007, The Journal of Neuroscience.

[37]  J. Steitz,et al.  AU-Rich-Element-Mediated Upregulation of Translation by FXR1 and Argonaute 2 , 2007, Cell.

[38]  R. Deacon Assessing nest building in mice , 2006, Nature Protocols.

[39]  Wim E. Crusio,et al.  Social behavior deficits in the Fmr1 mutant mouse , 2006, Behavioural Brain Research.

[40]  D. Nelson,et al.  The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo , 2006, Neurobiology of Disease.

[41]  M. Kai,et al.  Identification and Characterization of a Novel Human Type II Diacylglycerol Kinase, DGKκ* , 2005, Journal of Biological Chemistry.

[42]  E. De Schutter,et al.  Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome , 2005, Neuron.

[43]  C. B. Smith,et al.  Postadolescent Changes in Regional Cerebral Protein Synthesis: An In Vivo Study in the Fmr1 Null Mouse , 2005, The Journal of Neuroscience.

[44]  Atsushi Miyawaki,et al.  PKC Signaling Mediates Global Enhancement of Excitatory Synaptogenesis in Neurons Triggered by Local Contact with Astrocytes , 2004, Neuron.

[45]  Jernej Ule,et al.  CLIP Identifies Nova-Regulated RNA Networks in the Brain , 2003, Science.

[46]  I. Weiler,et al.  RNA Cargoes Associating with FMRP Reveal Deficits in Cellular Functioning in Fmr1 Null Mice , 2003, Neuron.

[47]  R. Anwyl,et al.  Group I Metabotropic Glutamate Receptor (mGluR)-Dependent Long-Term Depression Mediated via p38 Mitogen-Activated Protein Kinase Is Inhibited by Previous High-Frequency Stimulation and Activation of mGluRs and Protein Kinase C in the Rat Dentate Gyrus In Vitro , 2002, The Journal of Neuroscience.

[48]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[50]  C. Ehresmann,et al.  The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif , 2001, The EMBO journal.

[51]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[52]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Jonathan A. Cooper,et al.  The Phosphorylation of Eukaryotic Initiation Factor eIF4E in Response to Phorbol Esters, Cell Stresses, and Cytokines Is Mediated by Distinct MAP Kinase Pathways* , 1998, The Journal of Biological Chemistry.

[54]  P Chambon,et al.  Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. , 1998, Science.

[55]  I. Weiler,et al.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Brindley,et al.  Phosphatidate phosphohydrolase and signal transduction. , 1996, Chemistry and physics of lipids.

[57]  F. De Clerck,et al.  The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949. , 1989, The Journal of biological chemistry.

[58]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[59]  Dominique Muller,et al.  Activity-dependent PSD formation and stabilization of newly formed spines in hippocampal slice cultures. , 2008, Cerebral cortex.

[60]  M. Kai,et al.  Identification and characterization of a novel human type II diacylglycerol kinase, DGK kappa. , 2005, The Journal of biological chemistry.

[61]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[62]  É. Khandjian,et al.  The fragile X mental retardation protein is associated with ribosomes , 1996, Nature Genetics.